Product Categories
| Country: | China |
|---|---|
| Tel: | 020-61855200 |
| Mobile: | 13326451905 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Caliprazine impuritiesA | Details |
| Raxicept sodium impurity 3 | Details |
| Macitentan Impurity 42 | Details |
| L-salbutamol impurity B | Details |
| Aminobenzimidazole impurity 5 | Details |
| Dipropivacaine Impurity 5 | Details |
| Melphalan lmpurity 7 | Details |
| Melphalan lmpurity 5 | Details |
| Mexiletine Impurity 19 | C18H22O4S | 68164-73-8 | Details |
| Nintedanib Impurity 32 | Details |
| Mupirocin Impurity 5 | C26H44O9 | Details |
| Milbemycin EP impurities D | Details |
| Salbutamol impurity B (designated brand BP cat. No: 852) | Details |
| (2-hydroxy-2 - (3-hydroxyphenyl) ethyl) (methyl) amino) - 4-oxobuty-2-enoic acid | Details |
| Carbiramine related compound C | Details |
| Dipropivacaine Impurity 4 | Details |
| Raxicept sodium impurity 2 | Details |
| Chlorpromazine impurity D | Details |
| Tetracaine N-Oxide | C15H24N2O3 | 55750-02-2 | Details |
| Mupirocin EP Impurity H | Details |
| Mexiletine Impurity 18 | C11H16O2 | 26583-69-7 | Details |
| Fosinopril related compound B | Details |
| Tranexamic Acid Impurity F CRS（designated brand EP Y0002154） | Details |
| Ceftriaxone impurity 29(ene Isomer) | Details |
| Aminobenzimidazole impurity4 | Details |
| Lummakato impurities8 | Details |
| Rifampicin impurities5 | C44H52N4O13 | 13292-53-0 | Details |
| Meloxicam EP Impurity A | C12H13NO5S | 24683-26-9 | Details |
| N-(2-Quinoxaline)-sulfaquinoxalin. | Details |
| Ceftriaxone sodium impurity H | Details |
| 1-nitroso-1H-benzotriazole | Details |
| Impurity 1 of dapafinil mesylate | Details |
| Aminobenzimidazole impurity1 | Details |
| Antipyrine Impurity 8 | Details |
| Mupirocin Impurity 6 | C26H44O9 | Details |
| Clindamycin Phosphate Impurity G | Details |
| Nintedanib Impurity 41 | C9H10N2O3 | 121-95-9 | Details |
| Tranexamic acid impurity F | Details |
| Dexamethasone Impurity 24 | C38H59FO6 | 14899-36-6 | Details |
| Amphotericin B Impurity E | Details |
| Isoproterenol Impurity 27 | Details |
| Ataluren impurities2 | Details |
| Raxicept sodium impurity 4 | Details |
| Raxicept sodium impurity 1 | Details |
| Articaine Impurity 20 | C14H22N2O3S | 47066-35-3 | Details |
| Leuprorelin EP Impurity K | Details |
| Siliconized microcrystalline cellulose | Details |
| Dydrogesterone Impurity 14 | Details |
| Losartan system suitability | Details |
| Penicillin sodium EPimpurity F | Details |
| Betamethasone bromide | Details |
| Tetracaine Impurity 7 | C15H23NO2 | 92726-05-1 | Details |
| Benidipine Impurity I | C16H16N2O6 | Details |
| Non Sorodine Impurities2 | C26H36NO3 | Details |
| Febuxostat Impurity 32 | C12H12N2O | 1805770-41-5 | Details |
| Tetracaine Impurity 3 | C11H15NO2 | 94-14-4 | Details |
| Nintedanib Impurity 36 | Details |
| Betaxolol impurity a | Details |
| Lornoxicam Impurity 49 | C8H8N2O3 | 54166-60-8 | Details |
| Fosinopril related compound E | Details |
| Ceftriaxone impurity 30 (olefin isomer disodium salt) | Details |
| 4-{4-fluoro-3-[(4-nitrosopiperazin-1-yl)carbonyl]benzyl}phthalazin-1(2H)-one | Details |
| Impurity 2 of dapafinil mesylate | Details |
| Aminobenzimidazole impurity2 | Details |
| Nintedanib impurity 53 | C18H15NO4 | 1160293-22-0 | Details |
| Valsartan Impurity 3 | C24H29N5O3 | Details |
| Oxacillin sodium EP Impurity F | Details |
| Tetracaine Impurity 4 | C13H19NO2 | 94-32-6 | Details |
| Nintedanib Impurity 46 | C9H10Cl2N2O | 99846-70-5 | Details |
| Milbemycin EP impurities F | Details |
| Rifampicin impurities6 | Details |
| Milbemycin EP impurities I | Details |
| 8s-isopropyl-3 β- Mm hydroxymethylammonium bromide | Details |
| Articaine Impurity 21 | Details |
| Aminobenzimidazole | Details |
| Mexiletine Impurity 20 | Details |
| Nintedanib Impurity 33 | C10H14O3 | 2186-92-7 | Details |
| Fosinopril related compound F | Details |
| Lilalitine impurity 1 | C22H23N7O2 | Details |
| Bepotastine Impurity 3 | C28H32ClN3O4 | 210095-66-2 | Details |
| Lornoxicam Impurity 50 | C9H11NO6S2 | 106820-63-7 | Details |
| Nintedanib Impurity 35 | C10H9NO4 | 1895918-24-7 | Details |
| Nimesulide impurity D (control article) | Details |
| Dydrogesterone Impurity 15 | Details |
| Ethyl cinnamate impurity 1 | Details |
| Dipropivacaine Impurity 2 | Details |
| ProMethazine EP IMpurity B(Phenothiazine EP impurityB) | Details |
| Lapatinib Impurity 11 | C26H18ClN3O3 | 231278-83-4 | Details |
| Melphalan lmpurity 3 | C11H16Cl2N2O2 | 896715-19-8 | Details |
| Ticargrelor impurity 7 | C26H32F(18F)N6O4S | 2588537-76-0 | Details |
| Mupirocin EP Impurity G | Details |
| Fosfomycin tromethamine Impurity5(Disodium Salt) | Details |
| Ticagrelor system suitability for CRS | Details |
| Impurity 4 of dapafinil mesylate | Details |
| Aminobenzimidazole impurity3 | Details |
| Lummakato impurities6 | Details |
| Melphalan lmpurity 6 | C13H16Cl2N2O4 | 1951445-22-9 | Details |
| Meloxicam EP Impurity D | C16H17N3O4S2 | 1331636-17-9 | Details |
| Cefmetazole Impurity 21 | Details |
| Articaine Impurity 17 | C12H18N2O3S | 2602451-78-3 | Details |
| Product Total： Product Page： | ||||
| 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 | ||||